Eukaryotic Pathogens Innovation Center (EPIC)
Clemson to offer post-grad degrees in growing medical biophysics field
Upstate biochemistry senior named Clemson’s first Rhodes Scholar
Creating opportunities for students
Clemson scientist receives $1.77M NIH grant to continue research on deadly parasites
The Eukaryotic Pathogens Innovation Center (EPIC), founded in January 2013, is an interdisciplinary research cooperative at Clemson University. It stands at the forefront of biomedical research on eukaryotic pathogens, which are the causative agents of some of the most devastating and intractable diseases of humans including malaria, amoebic dysentery, sleeping sickness, Chagas disease, and fungal meningitis. Globalization has resulted in an increase in such infections in the US and many eukaryotic pathogens are also classified as bioterrorism agents and/or neglected tropical diseases (NTDs). The global importance of these pathogens is what motivates our faculty members, who have established a lengthy track record of major contributions in this area of research.